Anti-TNF-alpha (infliximab) in complex regional pain syndrome.

Trial Profile

Anti-TNF-alpha (infliximab) in complex regional pain syndrome.

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Nov 2010

At a glance

  • Drugs Infliximab (Primary)
  • Indications Complex regional pain syndromes
  • Focus Therapeutic Use
  • Acronyms InCRePaS
  • Most Recent Events

    • 02 Feb 2010 New source identified and integrated (Netherlands Trial Register record no. NTR449).
    • 19 Aug 2009 Status changed from not stated to completed as reported by ISRCTN: Current Controlled Trials record.
    • 08 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top